Medline Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|
| Revenue | $7.69B | $7.35B | $6.89B | $6.64B |
| Cost of Revenue | $5.47B | $5.51B | $4.98B | $4.82B |
| Gross Profit | $2.22B | $1.84B | $1.91B | $1.82B |
| Gross Margin | 28.8% | 25.0% | 27.7% | 27.5% |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | $1.30B | $1.23B | $1.07B | $1.07B |
| Operating Income | $395.0M | $422.0M | $642.0M | $571.0M |
| Operating Margin | 5.1% | 5.7% | 9.3% | 8.6% |
| Interest Expense | — | — | — | — |
| Pretax Income | $235.0M | $291.0M | $359.0M | $338.0M |
| Income Tax Expense | $96.0M | $52.0M | $26.0M | $16.0M |
| Net Income | $139.0M | $239.0M | $329.0M | $319.0M |
| Net Margin | 1.8% | 3.3% | 4.8% | 4.8% |
| EPS (Basic) | $0.07 | $0.16 | — | — |
| EPS (Diluted) | $0.07 | $0.16 | — | — |
| Shares Outstanding (Basic) | 856.7M | 819.1M | — | — |
| Shares Outstanding (Diluted) | 860.9M | 824.8M | — | — |
| Dividends Per Share | — | — | — | — |